These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 20519870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ, Boer KA, Scheefhals AP, Anzion RB, Bos RP.
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
    Hedmer M, Tinnerberg H, Axmon A, Jönsson BA.
    Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Occupational exposure to antineoplastic drugs in four Italian health care settings.
    Sottani C, Porro B, Imbriani M, Minoia C.
    Toxicol Lett; 2012 Aug 13; 213(1):107-15. PubMed ID: 21477641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
    Ensslin AS, Stoll Y, Pethran A, Pfaller A, Römmelt H, Fruhmann G.
    Occup Environ Med; 1994 Apr 13; 51(4):229-33. PubMed ID: 8199663
    [Abstract] [Full Text] [Related]

  • 11. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
    Palamini M, Dufour A, Therrien R, Delisle JF, Mercier G, Gagné S, Caron N, Bussières JF.
    J Oncol Pharm Pract; 2020 Dec 13; 26(8):1864-1870. PubMed ID: 32138611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Environmental contamination with methotrexate in Canadian community pharmacies.
    Merger D, Tanguay C, Langlois É, Lefebvre M, Bussières JF.
    J Am Pharm Assoc (2003); 2013 Dec 13; 53(4):423-6. PubMed ID: 23892817
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
    Villa A, Molimard M, Bignon E, Martinez B, Rouyer M, Mathoulin-Pelissier S, Baldi I, Verdun-Esquer C, Canal-Raffin M.
    BMJ Open; 2019 Nov 10; 9(11):e033040. PubMed ID: 31712349
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.